Table 4.

Differential Diagnosis of PBL

PBLCommon DLBCLPlasmacytomaBL
Size of the tumor cell Large Large Intermediate Intermediate 
Plasmablastic differentiation4-150 − to −/+ −/+ − 
CD20 (L26) − to −/+ − 
CD45 (LC) − to −/+ − 
CD79a (JCB117) − to + +50% 
VS38c − to −/+ − 
Ki-67 (MIB-1) PI > 90% PI: 30% to 90% PI: 5% to 60% PI > 95% 
Ig heavy chain G, M, and/or D G, A, M, or D 
BCL-2 (124) − to + − to + − to + − 
BCL-6 (PG-B6P) − to −/+ +50% Not known +100% 
PBLCommon DLBCLPlasmacytomaBL
Size of the tumor cell Large Large Intermediate Intermediate 
Plasmablastic differentiation4-150 − to −/+ −/+ − 
CD20 (L26) − to −/+ − 
CD45 (LC) − to −/+ − 
CD79a (JCB117) − to + +50% 
VS38c − to −/+ − 
Ki-67 (MIB-1) PI > 90% PI: 30% to 90% PI: 5% to 60% PI > 95% 
Ig heavy chain G, M, and/or D G, A, M, or D 
BCL-2 (124) − to + − to + − to + − 
BCL-6 (PG-B6P) − to −/+ +50% Not known +100% 

Abbreviations: +, expression of the antigen in the majority of cells, percentage of positive cases in a given subgroup of tumors; −, absence of antigen expression; −/+, weak antigen expression; BL, Burkitt's lymphoma; PI, proliferation index; DLBCL, diffuse large B-cell lymphoma.

F4-150

Abundant deeply basophilic cytoplasm with a paranuclear hof and large chromatin-poor nuclei containing prominent nucleoli.

Close Modal

or Create an Account

Close Modal
Close Modal